Version 2.78

Part Description

LP417540-4   SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility. PMID: 31953166 Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.

The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus. Source: LOINC

Fully-Specified Name

Component
SARS coronavirus 2 Ab.IgG
Property
PrThr
Time
Pt
System
XXX
Scale
Ord
Method

Additional Names

Short Name
SARS-CoV-2 IgG Spec Ql
Display Name
SARS-CoV-2 (COVID-19) IgG Ql (Specimen)
Consumer Name Alpha Get Info
SARS-CoV-2 (COVID-19) IgG antibody, Specimen

Example Answer List: LL360-9

Source: Regenstrief Institute
Answer Code Score Answer ID
PositiveCopyright http://snomed.info/sct ID:10828004 Positive (qualifier value) LA6576-8
NegativeCopyright http://snomed.info/sct ID:260385009 Negative (qualifier value) LA6577-6

Basic Attributes

Class
MICRO
Type
Laboratory
First Released
Version 2.78
Last Updated
Version 2.78
Order vs. Observation
Both

Member of these Groups Get Info

LOINC Group Group Name
LG51018-6 SARSCoV2 antibody detection

Language Variants Get Info

Tag Language Translation
es-ES Spanish (Spain) Panel del SARS-CoV-2 (COVID-19) IgG:PrThr:Punto temporal:XXX:Ord:
fr-CA French (Canada) coronavirus 2 du SRAS, IgG:Présence-Seuil:Temps ponctuel:XXX:Ordinal:
it-IT Italian (Italy) SARS coronavirus 2 Ab.IgG:PrThr:Pt:XXX:Ord:
Synonyms: anticorpi IgG anticorpo Coronavirus della SARS Microbiologia Presenza o Soglia Punto nel tempo (episodio) SARS-CoV-2 (COVID-19)
nl-NL Dutch (Netherlands) SARS-CoV-2 As.IgG:aanwezigheid:moment:XXX:ordinaal:
Synonyms: antistof; antilichaam SARS-virus severe acute respiratory syndrome coronavirus 2; 2019-nCoV; 2019 novel coronavirus; COVID-19
pl-PL Polish (Poland) SARS-CoV-2 Ab.IgG:granica wykrywalności:punkt w czasie:XXX:półilościowy:
Synonyms: IgG Koronawirus Przeciwciała do wirusa SARS-CoV-2 (COVID-19) Przeciwciała IgG do SARS-CoV-2 (COVID-19)
zh-CN Chinese (China) SARS 冠状病毒 2 抗体.IgG:存在情况或阈值:时间点:XXX:序数型:
Synonyms: 2019 新型冠状病毒;2019 年新型冠状病毒;2019-nCoV;SARS-CoV-2;新型冠状病毒肺炎;新冠肺炎;Coronavirus disease 2019;COVID-19;冠状病毒疾病2019;严重急性呼吸综合征;severe acute respiratory syndrome;SARS;传染性非典型肺炎;infectious atypical pneumonia;非典 Ⅱ Ab.IgG;IgG;抗体 IgG Ab;自身抗体 II SARS;SARS 病毒;SARS-CoV;严重急性呼吸综合征;严重急性呼吸综合征病毒;萨斯病毒;非典;非典型肺炎;非典型肺炎病毒;非典病毒 不明的;其他;将在相应消息内其他部分之中加以详细说明;未作详细说明的;未作说明的;未做说明的标本;未加规定的;未加说明的标本;杂项 依次型;分类顺序型;定性的;序数型(或称等级型);性质上的;有序型;有序性分类应答;有序性分类结果;秩次型;等级型;筛查;顺序型 免疫球蛋白 G 存在情况;存在;存在与否;是否存在;阈值;界值;界限;阀值;临界值;存在情况(存在、存在与否、是否存在)或阈值(界值、界限、阀值、临界值) 微生物学;微生物学试验;微生物学试验(培养、DNA、抗原及抗体) 时刻;随机;随意;瞬间

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=105911-2